Latest filing published 16 Aug 2024 for Acrivon Therapeutics, Inc., €3,123.
Insider track record
Kristina Masson: trading record in brief
Kristina Masson is a declared insider of Acrivon Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 14 November 2022 and the latest from 14 August 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 16 August 2024 came the latest disclosure, a share grant for €3,123 in Acrivon Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kristina Masson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 490 shares@ US$7.0217.6% of flowCommon StockSEC:0000905148-24-002281:0
- 490 shares@ US$8.3621.3% of flowCommon StockSEC:0000905148-24-001491:0
- 579 shares@ US$3.4010.3% of flowCommon StockSEC:0000905148-24-000764:0
- 1,900 shares@ US$5.0850.8% of flowCommon StockSEC:0000905148-23-001476:0
- 26,707 shares0Common StockSEC:0001209191-22-057397:0
5 of 5 declarations
